loadpatents
name:-0.010045051574707
name:-0.0069851875305176
name:-0.0092160701751709
Roth; Howard S. Patent Filings

Roth; Howard S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roth; Howard S..The latest application filed is for "macrocyclic immunomodulators".

Company Profile
11.10.13
  • Roth; Howard S. - Sunnyvale CA
  • ROTH; Howard S. - Champaign IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Salt forms of a complement component C5A receptor
Grant 11,427,541 - Singh , et al. August 30, 2
2022-08-30
Macrocyclic Immunomodulators
App 20220119405 - MALATHONG; Viengkham ;   et al.
2022-04-21
Macrocyclic immunomodulators
Grant 11,059,834 - Malathong , et al. July 13, 2
2021-07-13
Immunomodulator Compounds
App 20210147356 - LANGE; Christopher ;   et al.
2021-05-20
Salt Forms Of A Complement Component C5a Receptor
App 20210139427 - SINGH; Rajinder ;   et al.
2021-05-13
Procaspase 3 Activation By Combination Therapy
App 20210128551 - HERGENROTHER; Paul J. ;   et al.
2021-05-06
Immunomodulator compounds
Grant 10,919,852 - Lange , et al. February 16, 2
2021-02-16
Indanes As Pd-l1 Inhibitors
App 20210008049 - MALATHONG; Viengkham ;   et al.
2021-01-14
Procaspase 3 activation by combination therapy
Grant 10,888,560 - Hergenrother , et al. January 12, 2
2021-01-12
Compounds For Treatment Of Pd-l1 Diseases
App 20210002229 - MALATHONG; Viengkham ;   et al.
2021-01-07
Macrocyclic Immunomodulators
App 20200055869 - MALATHONG; Viengkham ;   et al.
2020-02-20
Macrocyclic immunomodulators
Grant 10,392,405 - Malathong , et al. A
2019-08-27
Immunomodulator Compounds
App 20190135745 - LANGE; Christopher ;   et al.
2019-05-09
Procaspase 3 Activation By Combination Therapy
App 20190099418 - HERGENROTHER; Paul J. ;   et al.
2019-04-04
Macrocyclic Immunomodulators
App 20190048022 - MALATHONG; Viengkham ;   et al.
2019-02-14
Procaspase 3 activation by combination therapy
Grant 10,085,977 - Hergenrother , et al. October 2, 2
2018-10-02
Substituted piperazinyl acetohydrazide procaspase-activating compounds
Grant 9,663,482 - Hergenrother , et al. May 30, 2
2017-05-30
Procaspase 3 Activation By Combination Therapy
App 20160346277 - HERGENROTHER; Paul J. ;   et al.
2016-12-01
Procaspase 3 activation by combination therapy
Grant 9,399,035 - Hergenrother , et al. July 26, 2
2016-07-26
Enzyme-activating Compounds And Compositions
App 20160176833 - Hergenrother; Paul J. ;   et al.
2016-06-23
Enzyme-activating compounds and compositions
Grant 9,249,116 - Hergenrother , et al. February 2, 2
2016-02-02
Procaspase 3 Activation By Combination Therapy
App 20150017264 - Hergenrother; Paul J. ;   et al.
2015-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed